We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Apr 2019 to Apr 2024
--Bayer AG's (BAYN.XE) digestive medication Iberogast is at the center of an investigation by the Cologne public prosecutor's office for a possible connection with the death of a person who took the medication, German business magazine Handelsblatt reports.
--According to the publication, the conglomerate refused to add warnings about possible liver damage and failure to the drug's package leaflet for years.
--The company only added them last year, when it became known that a woman in Germany died of liver failure and interior bleeding who previously took the medication, Handelsblatt reports.
--Bayer wasn't immediately available for comment.
Full story (in German): https://bit.ly/2Y9Sncd
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
July 22, 2019 04:26 ET (08:26 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Bayer Chart |
1 Month Bayer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
